Ron J Keizer

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Venues

Therapeutic drug monitoring

Clinical pharmacokinetics

European journal of clinical pharmacology

Clinical pharmacology and therapeutics

InsightRX

Universiteit Utrecht (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

InsightRX May 01 2015

United States

Chief Scientific Officer

Pirana Software & Consulting BV

United States

CEO, founder

UCSF Department of Bioengineering and Therapeutic Sciences

United States

Post-doctoral fellow

Uppsala Universitet

Sweden

Post-doctoral fellow :: Pharmaceutical Biosciences

Slotervaartziekenhuis

Netherlands

PhD candidate :: Pharmacy & Pharmacology

Nederlands Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis

Netherlands

PhD candidate

Education History

Universiteit Utrecht

Netherlands

PHD

Publications

Dahham Alsoud, Dirk Jan A R Moes, Zhigang Wang, Rani Soenen, Zohra Layegh, Murray L Barclay, Tomoyuki Mizuno, Iris K Minichmayr, Ron J Keizer, Sebastian Georg Wicha, Gerrit J Wolbink, Jo Lydie Wilfried Lambert, Severine Vermeire, Annick de Vries, Konstantinos Papamichael, Núria Padullés-Zamora, Erwin Dreesen
Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. Therapeutic drug monitoring 46 (3) (2024)
Astrid Heida, Nynke G L Jager, Rob E Aarnoutse, Brenda C M de Winter, Huib de Jong, Ron J Keizer, Elisabeth A M Cornelissen, Rob Ter Heine
Model-informed dose optimization of mycophenolic acid in pediatric kidney transplant patients. European journal of clinical pharmacology (2024)
Dahham Alsoud, Dirk Jan A R Moes, Zhigang Wang, Rani Soenen, Zohra Layegh, Murray L Barclay, Tomoyuki Mizuno, Iris K Minichmayr, Ron J Keizer, Sebastian Georg Wicha, Gerrit J Wolbink, Jo Lydie Wilfried Lambert, Severine Vermeire, Annick de Vries, Konstantinos Papamichael, Núria Padullés-Zamora, Erwin Dreesen
Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. Therapeutic drug monitoring 46 (3) (2024)
Dahham Alsoud, Dirk Jan A R Moes, Zhigang Wang, Rani Soenen, Zohra Layegh, Murray L Barclay, Tomoyuki Mizuno, Iris K Minichmayr, Ron J Keizer, Sebastian Georg Wicha, Gerrit J Wolbink, Jo Lydie Wilfried Lambert, Severine Vermeire, Annick de Vries, Konstantinos Papamichael, Núria Padullés-Zamora, Erwin Dreesen
Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. Therapeutic drug monitoring (2024)
Jasmine H Hughes, Kara H Woo, Ron J Keizer, Srijib Goswami
Clinical decision support for precision dosing: opportunities for enhanced equity and inclusion in healthcare. Clinical pharmacology and therapeutics (2022)
Jasmine H Hughes, Dominic M H Tong, Jonathan D Faldasz, Adam Frymoyer, Ron J Keizer
Evaluation of Neonatal and Paediatric Vancomycin Pharmacokinetic Models and the Impact of Maturation and Serum Creatinine Covariates in a Large Multicentre Data Set. Clinical pharmacokinetics (2022)
John Fors, Natasha Strydom, William S Fox, Ron J Keizer, Radojka M Savic
Mathematical model and tool to explore shorter multi-drug therapy options for active pulmonary tuberculosis. PLoS computational biology 16 (8) (2020)
Stijn W van Beek, Rob Ter Heine, Ron J Keizer, Cecile Magis-Escurra, Rob E Aarnoutse, Elin M Svenson
Personalized Tuberculosis Treatment Through Model-Informed Dosing of Rifampicin. Clinical pharmacokinetics 58 (6) (2020)

Ron J Keizer.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ron J Keizer